Status: Not yet recruiting
Evaluation of Polidocanol Foam Sclerotherapy in Symptomatic Internal Hemorrhoids: A Prospective Study
To evaluate the efficacy, durability, safety, and clinical/endoscopic outcomes of standardized 3% polidocanol foam sclerotherapy in patients with symptomatic grade II-III internal hemorrhoids over a 12-month follow-up period.
Participants needed: 130
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Radwa Hussein Mohammed HasanenUpdated: Oct 8, 2026
Eligibility criteria
Age ≥18 years. [+6]
Goligher grade IV hemorrhoids. [+13]